Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04513691 · ClinicalTrials.gov registry record

A Chart Review of Newborns With the Presence of Confirmed or Suspected Maternal Chorioamnionitis and Utilization of the Early Onset Sepsis Calculator

A clinical trial, sponsored by Pediatrix.

Completed
Registry status
236
Enrollment target

NCT04513691 is a clinical trial that has completed, run by Pediatrix. The registered enrollment target is 236 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04513691 has completed, sponsored by Pediatrix.

COMPLETED
Registry status
236 participants
Enrollment target

Study Summary

This study will review practices in relation to chorioamnionitis (CAM) before and after to the implementation of the Neonatal Early-Onset Sepsis (EOS) Risk Calculator to determine the effect in the nursery at Banner - University Medical Center Phoenix. Newborns enrolled will be at least 35 weeks gestational age (GA) and have a maternal diagnosis of at least suspected or confirmed CAM. The data will include those newborns whose assessment and treatment were not guided by the EOS calculator which was implemented on August 28, 2019 and those with which the EOS calculator was utilized. A secondary objective is to show the economic impact with utilization of the EOS calculator. Data collected will include full laboratory workups including complete blood counts (CBC), blood cultures, antibiotic usage, length of time in the newborn nursery and total length of stay.

Interventions

  • DIAGNOSTIC_TEST EOS Calculator

Trial Details

FieldValue
Enrollment Target 236 participants
Start Date 2020-09-30
Est. Completion 2022-08-10

Sponsor

Pediatrix

28 total trials

What the Registry Record Tells You About NCT04513691

The ClinicalTrials.gov registry entry for NCT04513691 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 236 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pediatrix, which has 28 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which EOS Calculator is the first listed.

NCT04513691 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04513691 about?

NCT04513691 is a clinical study titled "A Chart Review of Newborns With the Presence of Confirmed or Suspected Maternal Chorioamnionitis and Utilization of the Early Onset Sepsis Calculator". This study will review practices in relation to chorioamnionitis (CAM) before and after to the implementation of the Neonatal Early-Onset Sepsis (EOS) Risk Calculator to determine the effect in the nursery at Banner - University Medical Center Phoenix. Newborns enrolled will be at least 35 weeks ges...

What is the current status of trial NCT04513691?

This trial is currently completed. The enrollment target is 236 participants. The study started on 2020-09-30. Estimated completion is 2022-08-10.

What interventions are being tested in trial NCT04513691?

The interventions under investigation include: EOS Calculator (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04513691?

This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.